Mary Jane Masson1, Leah D Carpenter, Mary L Graf, Lance R Pohl. 1. Molecular and Cellular Toxicology Section, Laboratory of Molecular Immunology, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA.
Abstract
UNLABELLED: Dimethyl sulfoxide (DMSO) is commonly used in biological studies to dissolve drugs and enzyme inhibitors with low solubility. Although DMSO is generally thought of as being relatively inert, it can induce biological effects that are often overlooked. An example that highlights this potential problem is found in a recent report demonstrating a pathogenic role for natural killer T (NKT) and natural killer (NK) cells in acetaminophen-induced liver injury (AILI) in C57Bl/6 mice in which DMSO was used to facilitate acetaminophen (APAP) dissolution. We report that NKT and NK cells do not play a pathologic role in AILI in C57Bl/6 mice in the absence of DMSO. Although AILI was significantly attenuated in mice depleted of NKT and NK cells prior to APAP treatment in the presence of DMSO, no such effect was observed when APAP was dissolved in saline. Because of this unexpected finding, the effects of DMSO on hepatic NKT and NK cells were subsequently investigated. When given alone, DMSO activated hepatic NKT and NK cells in vivo as evidenced by increased NKT cell numbers and higher intracellular levels of the cytotoxic effector molecules interferon-gamma (IFN-gamma) and granzyme B in both cell types. Similarly, when used as a solvent for APAP, DMSO again increased NKT cell numbers and induced IFN-gamma and granzyme B expression in both cell types. CONCLUSION: These data demonstrate a previously unappreciated effect of DMSO on hepatic NKT and NK cells, suggesting that DMSO should be used cautiously in experiments involving these cells.
UNLABELLED: Dimethyl sulfoxide (DMSO) is commonly used in biological studies to dissolve drugs and enzyme inhibitors with low solubility. Although DMSO is generally thought of as being relatively inert, it can induce biological effects that are often overlooked. An example that highlights this potential problem is found in a recent report demonstrating a pathogenic role for natural killer T (NKT) and natural killer (NK) cells in acetaminophen-induced liver injury (AILI) in C57Bl/6 mice in which DMSO was used to facilitate acetaminophen (APAP) dissolution. We report that NKT and NK cells do not play a pathologic role in AILI in C57Bl/6 mice in the absence of DMSO. Although AILI was significantly attenuated in mice depleted of NKT and NK cells prior to APAP treatment in the presence of DMSO, no such effect was observed when APAP was dissolved in saline. Because of this unexpected finding, the effects of DMSO on hepatic NKT and NK cells were subsequently investigated. When given alone, DMSO activated hepatic NKT and NK cells in vivo as evidenced by increased NKT cell numbers and higher intracellular levels of the cytotoxic effector molecules interferon-gamma (IFN-gamma) and granzyme B in both cell types. Similarly, when used as a solvent for APAP, DMSO again increased NKT cell numbers and induced IFN-gamma and granzyme B expression in both cell types. CONCLUSION: These data demonstrate a previously unappreciated effect of DMSO on hepatic NKT and NK cells, suggesting that DMSO should be used cautiously in experiments involving these cells.
Authors: C M Hogaboam; C L Bone-Larson; M L Steinhauser; A Matsukawa; J Gosling; L Boring; I F Charo; K J Simpson; N W Lukacs; S L Kunkel Journal: Am J Pathol Date: 2000-04 Impact factor: 4.307
Authors: Hasan El-Hassan; Khurshid Anwar; Patricia Macanas-Pirard; Mark Crabtree; Sek C Chow; Victoria L Johnson; Pauline C Lee; Richard H Hinton; Shirley C Price; George E N Kass Journal: Toxicol Appl Pharmacol Date: 2003-09-01 Impact factor: 4.219
Authors: Zhiping Li; Jude A Oben; Shiqi Yang; Huizhi Lin; Elizabeth A Stafford; Mark J Soloski; Steven A Thomas; Anna Mae Diehl Journal: Hepatology Date: 2004-08 Impact factor: 17.425
Authors: Y Kaneko; M Harada; T Kawano; M Yamashita; Y Shibata; F Gejyo; T Nakayama; M Taniguchi Journal: J Exp Med Date: 2000-01-03 Impact factor: 14.307
Authors: M J Smyth; K Y Thia; S E Street; E Cretney; J A Trapani; M Taniguchi; T Kawano; S B Pelikan; N Y Crowe; D I Godfrey Journal: J Exp Med Date: 2000-02-21 Impact factor: 14.307
Authors: Daniel J Antoine; Rosalind E Jenkins; James W Dear; Dominic P Williams; Mitchell R McGill; Matthew R Sharpe; Darren G Craig; Kenneth J Simpson; Hartmut Jaeschke; B Kevin Park Journal: J Hepatol Date: 2012-01-17 Impact factor: 25.083
Authors: Michael K Connolly; Diego Ayo; Ashim Malhotra; Michael Hackman; Andrea S Bedrosian; Junaid Ibrahim; Napoleon E Cieza-Rubio; Andrew H Nguyen; Justin R Henning; Monica Dorvil-Castro; H Leon Pachter; George Miller Journal: Hepatology Date: 2011-08-08 Impact factor: 17.425
Authors: Anna K Kopec; Nikita Joshi; Holly Cline-Fedewa; Anna V Wojcicki; Jessica L Ray; Bradley P Sullivan; John E Froehlich; Brendan F Johnson; Matthew J Flick; James P Luyendyk Journal: J Hepatol Date: 2016-12-10 Impact factor: 25.083
Authors: Isaac Downs; Tak Yee Aw; Jianfeng Liu; Patrick Adegboyega; Maureen N Ajuebor Journal: Biochem Biophys Res Commun Date: 2012-10-15 Impact factor: 3.575
Authors: Brittany V Martin-Murphy; Douglas J Kominsky; David J Orlicky; Terrence M Donohue; Cynthia Ju Journal: Hepatology Date: 2013-01-18 Impact factor: 17.425
Authors: Mohammed Bourdi; Midhun C Korrapati; Mala Chakraborty; Steven B Yee; Lance R Pohl Journal: Biochem Biophys Res Commun Date: 2008-06-27 Impact factor: 3.575